<DOC>
	<DOCNO>NCT00210249</DOCNO>
	<brief_summary>Number elderly people 70 increase France . In 2002 , south-west , 273,741 75 year , i.e . 9.2 % Aquitaine population . Incidence cancer old age 16,500 new case per year , fifty percent people cancer . Treatment modalities elderly people one 70 priority `` Plan cancer '' institute French government . They therapeutic trial dedicate . Oncologists hesitate treat either afraid inducing toxicity break quality life . Consequently , decide launch protocol oncologist geriatricians principal aim find geriatric assessment data help well predict chemotherapy toxicity , loss autonomy survival . We plan accrue 360 patient diagnosed cancer , include digestive , pulmonary , prostate , lymphoma , bladder , ovary cancer first-line chemotherapy plan . Patients initially classify accord usual method medical oncology practice three group : patient receive standard treatment , reduced standard treatment treatment adapt frail condition . Around Aquitaine , , organise seven team compose one geriatrician one nurse . Two kind team activate : one cover ten treatment sit Bordeaux area six sedentary team work half day week designate hospital . Geriatric evaluation include test cognitive function ( MMS ) , nutritional status ( MNA ) , co-morbidity ( CIRS-G ) , mobility ( Get Go ) , activity ( ADL ; IADL ) , quality life ( QLQ-C30 ) , depression ( GDS-15 ) Lachs-Balducci screening . Patients four geriatric evaluation : treatment , day 1 cycle 2 , day 1 cycle 4 , day 1 cycle 7 and/or end chemotherapy . Since September 2002 , 177 patient include , 112 finish : 47.3 % receive four evaluation , 16.1 % died end protocol , 14.3 % stop progression change treatment , 11.6 % meet administrative problem n't allow evaluation , 7.1 % decline inclusion 3.6 % finish treatment . The following result obtain : treatment , 73 % patient risk undernutrition ( MNA &lt; 23.5 ) , 1/3 one inability risk fall ( 38 % IADL &lt; 6 , 29 % get go &gt; 20seconds , 27 % ADL &gt; 1 , 34 % PS &lt; 1 ) , 28 % alter cognitive function ( MMS &lt; 24 ) , 29 % depressive ( GDS-15 &gt; 6 ) , 25 % thought poor quality life ( QLQ-C30 &lt; 4 ) . Protocol close September 2005 .</brief_summary>
	<brief_title>Development Evaluation Method Elderly Condition Patient Receiving Chemotherapy Treatment</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Digestive System Diseases</mesh_term>
	<mesh_term>Gastrointestinal Diseases</mesh_term>
	<mesh_term>Urinary Bladder Diseases</mesh_term>
	<mesh_term>Prostatic Diseases</mesh_term>
	<mesh_term>Ovarian Diseases</mesh_term>
	<criteria>Inclusion criterion : Age â‰¥ 70 year First line chemotherapy Cancer previously mention</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2005</verification_date>
	<keyword>Cancer</keyword>
	<keyword>elderly</keyword>
	<keyword>geriatric evaluation</keyword>
	<keyword>safety</keyword>
	<keyword>chemotherapy</keyword>
</DOC>